APS – controversies in diagnosis and management, critical overview of current guidelines
Abstract
Because the diagnosis of antiphospholipid syndrome is based on laboratory data, performance and interpretation of such tests is essential. Positivity in a single test among Lupus Anticoagulant (LA), anti cardiolipin (aCL) and anti β2-glycoprotein I (aβ2GPI) antibodies calls APS diagnosis into question. Conversely, triple positivity is strongly associated to thrombosis and pregnancy morbidity. A new era in studying APS should take into account different antiphospholipid antibodies profiles. Clinical studies on groups of patients that are homogeneous in terms of laboratory tests will provide information on the real risk of patients and on the real effect of therapeutic interventions.
Keywords: Antiphospholipid syndrome (APS) , Diagnosis , Patient laboratory profile , Therapeutic interventions
No full text is available. To read the body of this article, please view the PDF online.
To access this article, please choose from the options below
PII: S0049-3848(11)70014-7
doi:10.1016/S0049-3848(11)70014-7
© 2011 Elsevier Ltd. All rights reserved.
